S
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A109.0 KBSigilon Therapeutics, Inc.Feb 14, 4:36 PM ET·0001193125-24-036373
- SC 13D/A76.0 KBSigilon Therapeutics, Inc.Aug 14, 4:30 PM ET·0001193125-23-212400
- 8-K289.6 KBSigilon Therapeutics, Inc.Aug 11, 4:16 PM ET·0001193125-23-210739
- 10-Q7.2 MBSigilon Therapeutics, Inc.Aug 7, 8:11 AM ET·0001558370-23-013494
- SC 13D160.9 KBSigilon Therapeutics, Inc.Jul 7, 4:33 PM ET·0001193125-23-183831
- 8-K1.2 MBSigilon Therapeutics, Inc.Jun 29, 7:03 AM ET·0001104659-23-076070
- 8-K213.4 KBSigilon Therapeutics, Inc.May 22, 4:37 PM ET·0001558370-23-010309
- 10-Q6.2 MBSigilon Therapeutics, Inc.May 9, 8:10 AM ET·0001558370-23-008685
- 8-K339.5 KBSigilon Therapeutics, Inc.May 9, 7:37 AM ET·0001558370-23-008667
- 10-K11.6 MBSigilon Therapeutics, Inc.Mar 14, 4:25 PM ET·0001558370-23-003716
Insiders
10- AFEYAN NOUBAR10% Owner
- ANDERSON DANIEL GRIFFITHDirector
- Ashton-Rickardt PhilipChief Scientific Officer
- Cole Douglas G.Director
- CORZO DEYAChief Medical Officer
- Cox JohnDirector
- ELI LILLY & Co10% Owner
- Flagship Pioneering Inc.10% Owner
- Flagship Ventures Fund V General Partner LLC10% Owner
- Flagship Ventures Fund V, L.P.10% Owner
Tickers
No tickers on record
Addresses
business
100 BINNEY STREET STE 600
CAMBRIDGE, MA, 02142
mailing
100 BINNEY STREET STE 600
CAMBRIDGE, MA, 02142